Problem
Here are some articles on firms looking to makes strategic gains in the area of obesity drugs. Read all of them and comment on whether you thing this is a good area for firms to grow, what you see are the challenges and opportunities for firms planning to take advantage of this opportunity. How will this impact the US healthcare industry and your hospital in particular?